Never Miss Important Company Updates Again
Get AI-powered summaries of SEC filings delivered to your inbox
Follow your favorite stocks and get email alerts when they release important updates. Completely free.
Ironwood Pharmaceuticals is a biotech company focused on developing and commercializing gastrointestinal and rare disease therapies. Its flagship product, LINZESS, treats IBS-C and CIC globally through strategic partnerships. The company advances innovative pipeline candidates like apraglutide for short bowel syndrome and explores treatments for visceral pain conditions. Ironwood leverages its expertise in GI to bring life-changing medicines to patients worldwide.
This description was generated via AI from an annual report. Updated about 1 year ago.